Nuvation Bio NUVB Current ratio

Current ratio at other companies

Bristol-Myers SquibbBMY

1.5×+0.3×

PfizerPFE

1.2×0.0×

Rigel PharmaceuticalsRIGL

2.6×+0.4×

ImmunomeIMNM

21.7×+11.2×

Inhibrx Biosciences, Inc.INBX

6.5×+1.3×

ArriVent BioPharma, Inc.AVBP

14×-0.4×

FAQ

What is Nuvation Bio's current ratio?

Nuvation Bio (NUVB) reported current ratio of 8.4× in Q2 2026.

How has Nuvation Bio's current ratio changed year-over-year?

Nuvation Bio's current ratio decreased by 10.8% year-over-year, from 9.4× to 8.4×.

What is the long-term trend for Nuvation Bio's current ratio?

Over 5 years (2020 to 2025), Nuvation Bio's current ratio has grown at a -27.1% compound annual growth rate (CAGR), from 33.7× to 7×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.